LINC02118

Across TCGA pan-cancer cohorts, LINC02118 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated LINC02118 data layer.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher LINC02118 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02118 expression acts as an unfavorable survival marker, although some lineages such as PRAD show a favorable association.

CESC, TGCT, and KICH are the cancer types where LINC02118 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	OS	Tertile	III,IV	0.146	0.679	<.001	96	view →
TGCT	OS	Tertile	All	0.804	0.975	<.001	54	view →
KICH	DFS	Tertile	All	0.102	0.848	.004	39	view →
PAAD	DFS	Tertile	II,III,IV	0.220	0.455	.003	18	view →
SKCM	DFS	Tertile	All	0.292	0.625	.004	18	view →
PRAD	DFS	Tertile	All	0.976	0.750	.029	12	view →
LIHC	DFS	Tertile	All	0.149	0.529	.037	9	view →
ACC	OS	Tertile	All	0.277	0.644	.049	6	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

LINC02118–CESC (OS)

Open the CESC breakdown →